Enfusion, Inc.
ENFN
ENFN was delisted on the 17th of April, 2025.
64 hedge funds and large institutions have $931M invested in Enfusion, Inc. in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 26 increasing their positions, 15 reducing their positions, and 19 closing their positions.
73% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 15
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
4% less funds holding
Funds holding: 67 → 64 (-3)
16% less first-time investments, than exits
New positions opened: 16 | Existing positions closed: 19
38% less capital invested
Capital invested by funds: $1.51B → $931M (-$577M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
Ararat Capital Management
Westport,
Connecticut
|
+$15.6M |
| 2 |
Bank of New York Mellon
New York
|
+$10.9M |
| 3 |
Janus Henderson Group
London,
United Kingdom
|
+$6.18M |
| 4 |
1WCM
12 West Capital Management
New York
|
+$4.58M |
| 5 |
NCM
Nellore Capital Management
Redwood City,
California
|
+$2.45M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Ameriprise
Minneapolis,
Minnesota
|
-$19M |
| 2 |
BAMCO Inc
New York
|
-$5.06M |
| 3 |
Millennium Management
New York
|
-$4.56M |
| 4 |
SPPAM
Summit Partners Public Asset Management
Boston,
Massachusetts
|
-$3.12M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$2.5M |
ENFN Hedge Fund Activity: Q1 2022 in Review
64 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Enfusion, Inc. (ENFN) for Q1 2022, worth a combined $931M — down 38% from $1.51B a quarter earlier.
Sellers outnumbered buyers: 19 funds closed out of ENFN and 16 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 26 added.
The largest buyer was Ararat Capital Management, adding an estimated $15.6M. The largest seller was Ameriprise, exiting entirely with an estimated $19M sold.
- 64 institutional investors held Enfusion, Inc. (ENFN) as of Q1 2022, down from 67 in Q4 2021.
- Funds reported $931M of Enfusion, Inc. stock for Q1 2022, down 38% quarter-over-quarter.
- 16 funds opened new Enfusion, Inc. positions in Q1 2022 and 19 closed out, a net change of -3 holders.
- The largest Enfusion, Inc. buyer in Q1 2022 was Ararat Capital Management, an estimated $15.6M added.
- The largest Enfusion, Inc. seller in Q1 2022 was Ameriprise, an estimated $19M sold.
Based on aggregated 13F filings for Q1 2022.